Core Laboratories N.V Stock Hits New 52-Week High (CLB)

NEW YORK ( TheStreet) -- Core Laboratories N.V (NYSE: CLB) hit a new 52-week high Tuesday as it is currently trading at $134.84, above its previous 52-week high of $134.11 with 45,469 shares traded as of 10 a.m. ET. Average volume has been 374,900 shares over the past 30 days.

Core Laboratories N.V has a market cap of $5.18 billion and is part of the basic materials sector and energy industry. Shares are up 16.7% year to date as of the close of trading on Monday.

Core Laboratories N.V. engages in the provision of reservoir description, production enhancement, and reservoir management services to the oil and gas industry worldwide. The company has a P/E ratio of 34.4, above the average energy industry P/E ratio of 31.7 and above the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Core Laboratories N.V as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity, expanding profit margins, good cash flow from operations and impressive record of earnings per share growth. We feel these strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. You can view the full Core Laboratories N.V Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.

null

More from Markets

Stocks Tumble as Trump Calls Off North Korea Summit

Stocks Tumble as Trump Calls Off North Korea Summit

Stocks Could Easily Crater Into Memorial Day Weekend

Stocks Could Easily Crater Into Memorial Day Weekend

Video: Here Is How Real Estate Investment Trusts Can Boost Your Portfolio

Video: Here Is How Real Estate Investment Trusts Can Boost Your Portfolio

Celgene Shares Rise on Plans to Increase Stock Buybacks

Celgene Shares Rise on Plans to Increase Stock Buybacks

Global Stocks Slide as Trump's New Trade War Salvo Ignites Fresh Concern

Global Stocks Slide as Trump's New Trade War Salvo Ignites Fresh Concern